PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Oncogene

• Publication date

  2018-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41388-017-0040-zPMID 29379162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

  2017cited by this paper
• Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways

  2017cited by this paper
• DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling

  2016cited by this paper
• Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium

  2016cited by this paper
• It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.

  2016cited by this paper
• Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.

  2016cited by this paper
• Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors.

  2016cited by this paper
• Wnt signaling in cancer

  2016cited by this paper
• Cytoplasmic p21 is responsible for paclitaxel resistance in ovarian cancer A2780 cells.

  2015cited by this paper
• YAP Induces High-Grade Serous Carcinoma in Fallopian Tube Secretory Epithelial Cells

  2015cited by this paper
• Mutant p53 expression in fallopian tube epithelium drives cell migration

  2015cited by this paper
• Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer

  2015cited by this paper
• Comprehensive molecular characterization of gastric adenocarcinoma

  2014cited by this paper
• Pax genes: regulators of lineage specification and progenitor cell maintenance

  2014cited by this paper
• The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer

  2013cited by this paper
• A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia

  2013cited by this paper
• High-throughput chromatin immunoprecipitation for genome-wide mapping of in vivo protein-DNA interactions and epigenomic states

  2013cited by this paper
• Evaluating cell lines as tumour models by comparison of genomic profiles

  2013influential reference
• The Cancer Genome Atlas Pan-Cancer analysis project

  2013cited by this paper
• Cancer chromosomes going to POT1

  2013cited by this paper
• Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.

  2013cited by this paper
• Fallopian Tube Intraluminal Tumor Spread From Noninvasive Precursor Lesions: A Novel Metastatic Route in Early Pelvic Carcinogenesis

  2013cited by this paper
• Deconstructing p53 transcriptional networks in tumor suppression.

  2012cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012cited by this paper
• Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients

  2012cited by this paper
• Genome-Wide Analysis of Androgen Receptor Targets Reveals COUP-TF1 as a Novel Player in Human Prostate Cancer

  2012cited by this paper
• Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma.

  2012cited by this paper
• Value of PAX 8 Immunostaining in Tumor Diagnosis: A Review and Update

  2012cited by this paper
• Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients

  2012influential reference
• L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells.

  2011cited by this paper
• Pax8: A marker for carcinoma of Müllerian origin in serous effusions

  2011cited by this paper
• Integrated Genomic Analyses of Ovarian Carcinoma

  2011cited by this paper
• Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway

  2011cited by this paper
• Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer

  2011cited by this paper
• A Comprehensive Analysis of PAX8 Expression in Human Epithelial Tumors

  2011cited by this paper
• PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein

  2011cited by this paper
• PAX8 Reliably Distinguishes Ovarian Serous Tumors From Malignant Mesothelioma

  2010cited by this paper
• Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

  2010cited by this paper
• PAX2 Expression in Low Malignant Potential Ovarian Tumors and Low-Grade Ovarian Serous Carcinomas

  2009cited by this paper
• p21 in cancer: intricate networks and multiple activities

  2009cited by this paper
• p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint.

  2008cited by this paper
• Expression of Pax8 as a Useful Marker in Distinguishing Ovarian Carcinomas From Mammary Carcinomas

  2008cited by this paper
• Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.

  2007cited by this paper
• A candidate precursor to serous carcinoma that originates in the distal fallopian tube (J Pathol 2007; 211: 26–35)

  2007cited by this paper
• A candidate precursor to serous carcinoma that originates in the distal fallopian tube

  2007cited by this paper
• Male congenital hypothyroid Pax8-/- mice are infertile despite adequate treatment with thyroid hormone.

  2007cited by this paper
• Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy.

  2007cited by this paper
• The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome

  2006cited by this paper
• PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth.

  2006cited by this paper
• PAX8-Peroxisome Proliferator-Activated Receptor γ (PPARγ) Disrupts Normal PAX8 or PPARγ Transcriptional Function and Stimulates Follicular Thyroid Cell Growth

  2006cited by this paper
• Cytoplasmic p21Cip1 Is Involved in Ras-induced Inhibition of the ROCK/LIMK/Cofilin Pathway*

  2004cited by this paper
• Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.

  2004cited by this paper
• Atypical Epithelial Proliferation in Fallopian Tubes in Prophylactic Salpingo-oophorectomy Specimens from BRCA1 and BRCA2 Germline Mutation Carriers

  2004cited by this paper
• Getting your Pax straight: Pax proteins in development and disease.

  2002cited by this paper
• Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer

  2001cited by this paper
• Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells

  2001cited by this paper
• Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation

  1999cited by this paper
• p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells

  1998cited by this paper
• Follicular cells of the thyroid gland require Pax8 gene function

  1998cited by this paper
• Specific loss of apoptotic but not cell‐cycle arrest function in a human tumor derived p53 mutant.

  1996cited by this paper
• Loss of p53 function through PAX‐mediated transcriptional repression.

  1995cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines.

  1992cited by this paper

• Cancer Cell Dormancy and Chemotherapy Resistance

  2026cites this paper
• PAX8-positive conventional urothelial carcinomas of the urinary bladder and their distinct molecular profiles - A clinicopathologic study of 101 consecutive cases with next-generation sequencing in 20 cases.

  2026cites this paper
• SGK1 Inhibition Improved Mitochondrial Dysfunction and Astrocyte Senescence in Hepatic Encephalopathy via IL‐6/JAK2/STAT3 Signaling Pathway

  2025cites this paper
• Integrative multi-omic analysis reveals a PAX8-driven gene network linking tumor stemness to therapy response in ovarian cancer

  2025cites this paper
• Alterations in mitochondria and cellular senescence in aged sEH null female kidneys.

  2025cites this paper
• PAX Family, Master Regulator in Cancer

  2025cites this paper
• Establishment and characterization of preclinical model of primary ovarian squamous cell carcinoma

  2025cites this paper
• Silencing KMT2A with siRNA induces apoptosis and cell cycle arrest in high-grade serous ovarian carcinoma cells by modulating GOF p53-dependent pathways, highlighting its potential as a therapeutic target

  2025cites this paper
• ERK-mediated Cytoplasmic Retention of USP11 Contributes to Breast Cancer Cell Proliferation by Stabilizing Cytoplasmic p21

  2022cites this paper
• PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome

  2022cites this paper
• PAX8 as a Potential Target for Ovarian Cancer: What We Know so Far

  2022cites this paper
• PAX8 in the Junction between Development and Tumorigenesis

  2022cites this paper
• Identifying key multifunctional components shared by critical cancer and normal liver pathways via SparseGMM

  2022cites this paper
• The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17

  2022cites this paper
• SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer

  2022cites this paper
• Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment

  2021influential citation
• Adipose‐derived mesenchymal stem cells induced PAX8 promotes ovarian cancer cell growth by stabilizing TAZ protein

  2021cites this paper
• Chloroxine overrides DNA damage tolerance to restore platinum sensitivity in high-grade serous ovarian cancer

  2021cites this paper
• FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer

  2021cites this paper
• PAX8 plays an essential antiapoptotic role in uterine serous papillary cancer

  2021influential citation
• Mutated p53 in HGSC—From a Common Mutation to a Target for Therapy

  2021influential citation
• PAX8, an Emerging Player in Ovarian Cancer.

  2021cites this paper
• Chemical Synthesis of the PAX Protein Inhibitor EG1 and Its Ability to Slow the Growth of Human Colorectal Carcinoma Cells

  2021influential citation
• Forkhead box O1-p21 mediates macrophage polarization in postoperative cognitive dysfunction induced by sevoflurane.

  2020cites this paper
• Unraveling the Mysteries of PAX8 in Reproductive Tract Cancers

  2020cites this paper
• PAX8 orchestrates an angiogenic program through interaction with SOX17

  2020cites this paper
• miR-5193, regulated by FUT1, suppresses proliferation and migration of ovarian cancer cells by targeting TRIM11.

  2020cites this paper
• Transcription factors in epithelial ovarian cancer: Histotype-specific drivers and novel therapeutic targets.

  2020cites this paper
• Guanine nucleotide binding protein like-1 (GNL1) promotes cancer cell proliferation and survival through AKT/p21 CIP1 signaling cascade

  2020cites this paper
• DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer.

  2020cites this paper
• The identification of nuclear αvβ3 integrin in ovarian cancer: non-paradigmal localization with cancer promoting actions

  2020cites this paper
• Overview of PAX gene family: analysis of human tissue-specific variant expression and involvement in human disease

  2020cites this paper
• Comparison of single and module-based methods for modeling gene regulatory networks

  2019cites this paper
• PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors

  2019cites this paper
• Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma

  2019cites this paper
• Bioinformatic analysis of next-generation sequencing data to identify dysregulated genes in fibroblasts of idiopathic pulmonary fibrosis

  2019cites this paper
• PAX8 expression in high-grade serous ovarian cancer positively regulates attachment to ECM via Integrin β3

  2019cites this paper
• Altered expression of long noncoding RNAs in peripheral blood mononuclear cells in patients with impaired leptomeningeal collaterals after acute anterior large vessel occlusions.

  2019cites this paper
• HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma

  2019cites this paper
• Ovarian Cancer Stem Cell Heterogeneity.

  2019cites this paper
• Before and After: Comparison of Legacy and Harmonized TCGA Genomic Data Commons' Data.

  2019cites this paper
• Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton

  2019cites this paper
• UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer

  2018cites this paper